This study is in progress, not accepting new patients
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Summary
- Eligibility
- for people ages 18-110 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Zev Wainberg
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Zev Wainberg
HS Clinical Professor, Medicine. Authored (or co-authored) 138 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Trishula Therapeutics, Inc.
- ID
- NCT04306900
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 185 study participants
- Last Updated